Observational Study of the E-liac Branch Device for Treating Aortoiliac and Iliac Aneurysms in Real-World Patients

What this Trial Is About

This observational registry study focuses on patients with aortoiliac or iliac aneurysms who have been treated with the Iliac E-liac Branch Device from Artivion. It aims to investigate the medium and long-term outcomes of this device in a real-world group of consecutive patients. The research is sponsored by Federico II University and includes patients treated since 2015. Participants undergo treatment involving branch endovascular aneurysm repair Evar using the E-liac device, either alone or combined with other devices according to recent local surgical guidelines. The study collects data from patients receiving this specific treatment device, following their progress over time. During the study, researchers monitor outcomes such as aneurysm-related death and procedure-related reintervention at several time points 30 days, 6 months, 1, 2, 3, 4, and 5 years after the procedure. They also assess changes in aneurysm sac size over these intervals. The study tracks these measures to understand the devices performance over the medium and long term.

CAMpania PugliA bRanch Iliaco